Nyxoah SA Total Non-Operating Income/Expense 2021-2024 | NYXH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Nyxoah SA total non-operating income/expense from 2021 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Nyxoah SA Total Non-Operating Income/Expense 2021-2024 | NYXH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Nyxoah SA total non-operating income/expense from 2021 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$11.4B
Inspire Medical Systems (INSP)	$5.9B
Hims & Hers Health (HIMS)	$5B
Axonics (AXNX)	$3.6B
IRhythm Technologies (IRTC)	$2.7B
Enovis (ENOV)	$2.6B
Privia Health (PRVA)	$2.5B
Omnicell (OMCL)	$2.3B
Azenta (AZTA)	$2.2B
10x Genomics (TXG)	$1.9B
Clover Health Investments (CLOV)	$1.7B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.2B
Standard BioTools (LAB)	$800M
Fulgent Genetics (FLGT)	$589M
Butterfly Network (BFLY)	$558M
Talkspace (TALK)	$555M
Definitive Healthcare (DH)	$500M
Health Catalyst (HCAT)	$498M
Pulmonx (LUNG)	$294M
SOPHiA GENETICS SA (SOPH)	$230M
TruBridge (TBRG)	$203M
American Well (AMWL)	$135M
P3 Health Partners (PIII)	$134M
EUDA Health Holdings (EUDA)	$108M
HeartBeam (BEAT)	$68M
Future Health ESG (FHLT)	$65M
111 (YI)	$59M
Zepp Health (ZEPP)	$49M
SHL Telemedicine (SHLT)	$45M